PA Milligan

Good Practices in Model‐Informed Drug Discovery and Development: Practice, Application, and Documentation

SF Marshall, Rolf Burghaus, Valérie Cosson et al. · CPT Pharmacometrics & Systems Pharmacology · 2015 · 358 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +7

The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation Workshop

Efthymios Manolis, S Rohou, Robert Hemmings et al. · CPT Pharmacometrics & Systems Pharmacology · 2013 · 68 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +15

PKPD Modeling of VEGF, sVEGFR‐2, sVEGFR‐3, and sKIT as Predictors of Tumor Dynamics and Overall Survival Following Sunitinib Treatment in GIST

EK Hansson, MA Amantea, Paul Westwood et al. · CPT Pharmacometrics & Systems Pharmacology · 2013 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

PKPD Modeling of Predictors for Adverse Effects and Overall Survival in Sunitinib‐Treated Patients With GIST

EK Hansson, Guo Ma, MA Amantea et al. · CPT Pharmacometrics & Systems Pharmacology · 2013 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

MJ Swat, Stuart Moodie, NR Kristensen et al. · CPT Pharmacometrics & Systems Pharmacology · 2015 · 38 citations · Full text

Medicine, Pharmacology, Drug Design +6